Erythropoeitin Signaling in Macrophages Promotes Dying Cell Clearance and Immune Tolerance-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Erythropoeitin Signaling in Macrophages Promotes Dying Cell Clearance and Immune Tolerance

Published:2016-02 Issue:2 Volume:44 Page:287-302
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Luo Bangwei,Gan Woting,Liu Zongwei,Shen Zigang,Wang Jinsong,Shi Rongchen,Liu Yuqi,Liu Yu,Jiang Man,Zhang Zhiren,Wu Yuzhang

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference39 articles.

1. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement;Bijl;Ann. Rheum. Dis.,2006

2. Phospholipase D activation by sphingosine 1-phosphate regulates interleukin-8 secretion in human bronchial epithelial cells;Cummings;J. Biol. Chem.,2002

3. Clearance of apoptotic cells: implications in health and disease;Elliott;J. Cell Biol.,2010

4. Clearance: the last and often forgotten stage of apoptosis;Fadok;J. Mammary Gland Biol. Neoplasia,1999

5. Sphingosine 1-phosphate mediates chemotaxis of human primary fibroblasts via the S1P-receptor subtypes S1P1 and S1P3 and Smad-signalling;Gil;Cytoskeleton (Hoboken),2010

Cited by 161 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The protective effect of erythropoietin and its novel derived peptides in peripheral nerve injury;International Immunopharmacology;2024-09

2. Photodynamic Therapy Synergizes CD47 Blockade Strategy for Enhanced Antitumor Therapy;Molecular Pharmaceutics;2024-07-03

3. Erythropoietin induces tumour progression and CD39 expression on immune cells in a preclinical model of triple‐negative breast cancer;Immunology;2024-07-02

4. Clearing the Path: Exploring Apoptotic Cell Clearance in Inflammatory and Autoimmune Disorders for Therapeutic Advancements;Molecular Biotechnology;2024-06-27

5. “Find Me” and “Eat Me” signals: tools to drive phagocytic processes for modulating antitumor immunity;Cancer Communications;2024-06-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3